CCL2 and breast angiosarcoma: In conclusion, our study used publicly available GWAS data and MR analysis to identify three inflammatory cytokines (eotaxin, G-CSF, MCP-1/MCAF) and one metabolite X-12261 as risk factors for BA with a significant causal relationship.